Approval · Notice of Compliance 5810 · 1994
DIGIBIND: Notice of Compliance 5810
Issued November 21, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5810
- Date
- November 21, 1994
- Company
- Burroughs Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing
- Therapeutic class
- Specific antibody for digoxin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIGIBIND | 01929631 | — |
Medicinal ingredients
- DIGOXIN IMMUNE FAB (OVINE) 40 MG per VIAL